25 results
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
30 Sep 24
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates
4:01pm
, and initiated dosing in our Phase 2/3 IHL-42X RePOSA trial. These achievements demonstrate our commitment to advancing new oral cannabinoids and psychedelic
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
with our commitment to delivering long-term value for our shareholders.
Lead Drug Candidates
The estimated addressable global market opportunity … in addition to intensive guidance on an efficient development program beginning as early as Phase 1, and FDA organizational commitment to expedited
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
or commitment in existence prior to such receipt. This Guarantee shall continue to be effective or be reinstated, notwithstanding any such notice, if at any
8-K
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
, as a commitment fee, that number of Common Shares equal to 250,000 divided by the simple average of the daily VWAP of the Common Shares during the five
8-K
EX-10.1
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
as follows:
Article I
CERTAIN DEFINITIONS
“Advance” shall mean the portion of the Commitment Amount requested by the Company in an Advance Notice … ” shall have the meaning set forth in Section 2.06.
“Closing” shall have the meaning set forth in Section 2.05.
“Commitment Amount” shall mean $50.00
S-1/A
8piqq2mtw
17 Jul 24
IPO registration (amended)
8:47am
S-1
dcjgsekh22 xdg4ob
3 Jul 24
IPO registration
6:29am
8-K
EX-10.2
8ty5ycvage 6w
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-14.1
kfmmyv0n 3i9t
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
ckxa8937bdio
1 Sep 23
Report of Foreign Private Issuer
12:00am
20-F
EX-4.11
7f0ue
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
i5xiqea3vkcvxx7xw
19 Sep 22
Report of Foreign Private Issuer
9:38pm
20FR12B/A
ceq08cqnpcgqbc
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
qc3n26dfsnfi2pzuxvwc
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
20FR12B
qbf1gst6 ymwcck
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
EX-4.3
0zlfzstl q37hxg
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
EX-4.2
jxwqbd 03z6b3w7hazi
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
F-1/A
1l86yau7ipjd2fm48lu
7 Dec 21
Registration statement (foreign) (amended)
5:21pm
F-1/A
js40y
23 Nov 21
Registration statement (foreign) (amended)
3:28pm